» Authors » Caglar Unal

Caglar Unal

Explore the profile of Caglar Unal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 42
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Erdogan Iyigun Z, Ozmen T, Ilgun S, Nakipoglu C, Ozkurt E, Celebi F, et al.
Eur J Breast Health . 2025 Jan; 21(1):40-45. PMID: 39744892
Objective: The aim of this study was to evaluate the relationship between subclinical lymphedema identified prior to surgical intervention and clinical lymphedema observed in the late period, the incidence of...
2.
Akyildiz A, Guven D, Koksal B, Karaoglan B, Kivrak D, Ismayilov R, et al.
Eur Arch Otorhinolaryngol . 2024 May; 281(9):4991-4999. PMID: 38795147
Objectives: Head and neck cancers (HNCs) represent a significant global health concern due to high morbidity and mortality rates. Despite therapeutic advances, the prognosis for advanced or recurrent cases remains...
3.
Kayan Tapan T, Celebi F, Yaghouti K, Agacayak F, Ilgun S, Soybir G, et al.
Eur J Breast Health . 2024 Apr; 20(2):117-121. PMID: 38571683
Objective: Differences in individual muscle/fat volumes may change the effectiveness of chemotherapy. In this study, the relationship between trunkal muscle and fat volume and body mass index (BMI) obtained before...
4.
Unal C, Saglam S
J Cancer Res Ther . 2024 Mar; 20(1):464-466. PMID: 38554365
We report a case of the 46-year-old female patient, who presented with diffuse nodular liver calcifications on computed tomography. Histopathology of the calcified nodules revealed neuroendocrine tumors (NETs). Calcified NET...
5.
Kurt S, Ilgun A, Ozkurt E, Soybir G, Alco G, Unal C, et al.
World J Surg Oncol . 2024 Mar; 22(1):82. PMID: 38519998
Background: Surgery remains a priority for breast cancer treatment. This study aimed to compare the cosmetic outcomes of oncoplastic patients who had undergone breast-conserving surgery, mini-LDF (latissimus dorsi flap), and...
6.
Tasci E, Oyan B, Sonmez O, Mutlu A, Atci M, Sakin A, et al.
BMC Cancer . 2024 Jan; 24(1):114. PMID: 38262962
No abstract available.
7.
Tasci E, Oyan B, Sonmez O, Mutlu A, Atci M, Sakin A, et al.
BMC Cancer . 2024 Jan; 24(1):16. PMID: 38166764
Background: The optimal treatment for metastatic colorectal cancer (mCRC) after the second line is still controversial. Regorafenib has been the standard of care in this setting as it improved overall...
8.
Unal C, Saglam S
Cancers (Basel) . 2023 Dec; 15(23). PMID: 38067391
Addressing the persistent challenges in treating metastatic neuroendocrine tumors (NETs) demands ongoing refinement and innovation in therapeutic strategies. This study investigates the potential advantages of combining metronomic temozolomide (mTMZ) with...
9.
Akyildiz A, Guven D, Ozluk A, Ismayilov R, Mutlu E, Umit Unal O, et al.
Medicine (Baltimore) . 2023 Nov; 102(45):e35950. PMID: 37960746
The aim of the study was to evaluate the real-world clinical outcomes of atezolizumab and bevacizumab (Atez/Bev) as the initial therapy for advanced hepatocellular carcinoma (HCC). We retrospectively analyzed 65...
10.
Unal C, Ordu C, Ozmen T, Ilgun A, Celebi F, Baysal B, et al.
Curr Oncol . 2023 Oct; 30(10):9217-9229. PMID: 37887566
Estradiol (E2), a follicle-stimulating hormone (FSH), AMH, and inhibin B levels, along with AFC and MOV, are used to determine ovarian reserve in pre-menopausal women. Studies have shown that AMH...